Proof-of-Concept Study of MSP3-LSP Vaccine to Protect Against Malaria in Africa
Clinical trial NCT01341704 · COMPLETED
Trial details
- NCT number
- NCT01341704
- Sponsor
- Vac4All
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2011-12-01
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.